Open Access
Med Sci (Paris)
Volume 37, Number 10, Octobre 2021
Page(s) 833 - 835
Section Le Magazine
Published online 14 October 2021
  1. Sharabi K, Tavares CD, Rines AK, Puigserver P. Molecular pathophysiology of hepatic glucose production. Mol Asp Med 2015 ; 46 : 21–33. [Google Scholar]
  2. Shulman GI, Landau BR. Pathways of glycogen repletion. Physiol Rev 1992 ; 72 : 1019–1035. [CrossRef] [PubMed] [Google Scholar]
  3. Alessi DR, Sakamoto K, Bayascas JR. LKB1-dependent signaling pathways. Annu Rev Biochem 2006 ; 75 : 137–163. [CrossRef] [PubMed] [Google Scholar]
  4. Ruderman NB, Carling D, Prentki M, Cacicedo JM. AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest 2013 ; 123 : 2764–2772. [CrossRef] [PubMed] [Google Scholar]
  5. Shaw RJ, Lamia KA, Vasquez D, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005 ; 310 : 1642–1646. [CrossRef] [PubMed] [Google Scholar]
  6. Patel K, Foretz M, Marion A, et al. The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver. Nat Commun 2014 ; 5 : 4535. [CrossRef] [PubMed] [Google Scholar]
  7. Just PA, Charawi S, Denis RGP, et al. Lkb1 suppresses amino acid-driven gluconeogenesis in the liver. Nat Commun 2020; 11 : 6127. [CrossRef] [PubMed] [Google Scholar]
  8. Rowsell EV, Snell K, Carnie JA, Al-Tai AH. Liver-L-alanine-glyoxylate and L-serine-pyruvate aminotransferase activities: an apparent association with gluconeogenesis. Biochem J 1969 ; 115 : 1071–1073. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.